IOL CHEMICALS & PHARM. | PARENT.DRUGS | IOL CHEMICALS & PHARM./ PARENT.DRUGS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.7 | -0.1 | - | View Chart |
P/BV | x | 1.6 | - | - | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. PARENT.DRUGS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
PARENT.DRUGS Mar-21 |
IOL CHEMICALS & PHARM./ PARENT.DRUGS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 3 | 16,930.6% | |
Low | Rs | 272 | 3 | 10,469.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 4.1 | 9,254.7% | |
Earnings per share (Unadj.) | Rs | 23.7 | -40.8 | -58.1% | |
Cash flow per share (Unadj.) | Rs | 31.6 | -35.0 | -90.2% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | -229.0 | -112.1% | |
Shares outstanding (eoy) | m | 58.71 | 29.82 | 196.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.7 | 151.5% | |
Avg P/E ratio | x | 17.1 | -0.1 | -24,145.1% | |
P/CF ratio (eoy) | x | 12.8 | -0.1 | -15,549.4% | |
Price / Book Value ratio | x | 1.6 | 0 | -12,501.6% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 86 | 27,602.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 145 | 1,159.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 122 | 18,220.8% | |
Other income | Rs m | 256 | 1 | 40,015.6% | |
Total revenues | Rs m | 22,427 | 122 | 18,336.4% | |
Gross profit | Rs m | 2,257 | -118 | -1,916.8% | |
Depreciation | Rs m | 462 | 173 | 266.4% | |
Interest | Rs m | 165 | 1,254 | 13.1% | |
Profit before tax | Rs m | 1,887 | -1,545 | -122.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | -328 | -151.1% | |
Profit after tax | Rs m | 1,391 | -1,217 | -114.3% | |
Gross profit margin | % | 10.2 | -96.8 | -10.5% | |
Effective tax rate | % | 26.2 | 21.2 | 123.8% | |
Net profit margin | % | 6.3 | -1,000.3 | -0.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 681 | 1,420.0% | |
Current liabilities | Rs m | 5,025 | 11,436 | 43.9% | |
Net working cap to sales | % | 20.9 | -8,839.3 | -0.2% | |
Current ratio | x | 1.9 | 0.1 | 3,231.7% | |
Inventory Days | Days | 43 | 375 | 11.6% | |
Debtors Days | Days | 8 | 0 | - | |
Net fixed assets | Rs m | 11,017 | 3,343 | 329.6% | |
Share capital | Rs m | 587 | 298 | 196.9% | |
"Free" reserves | Rs m | 14,490 | -7,127 | -203.3% | |
Net worth | Rs m | 15,077 | -6,829 | -220.8% | |
Long term debt | Rs m | 0 | 1,072 | 0.0% | |
Total assets | Rs m | 20,684 | 4,024 | 514.0% | |
Interest coverage | x | 12.5 | -0.2 | -5,380.4% | |
Debt to equity ratio | x | 0 | -0.2 | -0.0% | |
Sales to assets ratio | x | 1.1 | 0 | 3,544.6% | |
Return on assets | % | 7.5 | 0.9 | 813.0% | |
Return on equity | % | 9.2 | 17.8 | 51.8% | |
Return on capital | % | 13.6 | 5.0 | 269.7% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 1,253 | 97.6% | |
From Investments | Rs m | -1,200 | 1 | -193,548.4% | |
From Financial Activity | Rs m | -41 | -1,254 | 3.3% | |
Net Cashflow | Rs m | -18 | -1 | 3,607.8% |
Indian Promoters | % | 48.2 | 73.3 | 65.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | 17,000.0% | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 26.7 | 194.0% | |
Shareholders | 130,003 | 7,129 | 1,823.6% | ||
Pledged promoter(s) holding | % | 0.0 | 94.5 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | PARENT.DRUGS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.11% | 4.63% | 0.45% |
1-Month | 5.76% | 9.71% | 2.55% |
1-Year | -2.63% | -19.48% | 56.14% |
3-Year CAGR | -12.88% | 8.97% | 15.22% |
5-Year CAGR | 16.82% | -19.84% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the PARENT.DRUGS share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of PARENT.DRUGS the stake stands at 73.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of PARENT.DRUGS.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
PARENT.DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of PARENT.DRUGS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.